Clinical Trials Browser

Phase 2/3 × envafolimab × Clear all

NCT06959693 2025-05-06

A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

Phase 2/3 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms